相似文献
1
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season.
Euro Surveill. 2017 Oct;22(41). doi: 10.2807/1560-7917.ES.2017.22.41.17-00645.
2
2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: pooled analysis from a European network of hospitals. A pilot study.
PLoS One. 2013;8(4):e59681. doi: 10.1371/journal.pone.0059681. Epub 2013 Apr 2.
3
2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.
Euro Surveill. 2015 Jan 15;20(2):21011. doi: 10.2807/1560-7917.es2015.20.2.21011.
4
Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine.
Influenza Other Respir Viruses. 2020 May;14(3):302-310. doi: 10.1111/irv.12714. Epub 2020 Feb 5.
5
Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network.
Hum Vaccin Immunother. 2016 May 3;12(5):1217-24. doi: 10.1080/21645515.2015.1126013. Epub 2016 Feb 2.
6
Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe.
Euro Surveill. 2017 Feb 16;22(7). doi: 10.2807/1560-7917.ES.2017.22.7.30464.
7
Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season.
Euro Surveill. 2019 Aug;24(31). doi: 10.2807/1560-7917.ES.2019.24.31.1800461.
8
Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
Euro Surveill. 2014 Feb 13;19(6):20701. doi: 10.2807/1560-7917.es2014.19.6.20701.
9
Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Euro Surveill. 2016;21(7):pii=30139. doi: 10.2807/1560-7917.ES.2016.21.7.30139.
10
Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.
Euro Surveill. 2013 Jan 31;18(5):20390. doi: 10.2807/ese.18.05.20390-en.
引用本文的文献
1
Impact of Influenza Vaccination on the Burden of Severe Influenza in the Elderly: Spain, 2017-2020.
Vaccines (Basel). 2023 Jun 17;11(6):1110. doi: 10.3390/vaccines11061110.
2
Does repeated influenza vaccination attenuate effectiveness? A systematic review and meta-analysis.
Lancet Respir Med. 2023 Jan;11(1):27-44. doi: 10.1016/S2213-2600(22)00266-1. Epub 2022 Sep 21.
3
Cost Effectiveness of Quadrivalent Versus Trivalent Inactivated Influenza Vaccines for the Portuguese Elderly Population.
Vaccines (Basel). 2022 Aug 9;10(8):1285. doi: 10.3390/vaccines10081285.
4
Clinical characteristics and population-based attack rates of respiratory syncytial virus versus influenza hospitalizations among adults-An observational study.
Influenza Other Respir Viruses. 2022 Mar;16(2):276-288. doi: 10.1111/irv.12914. Epub 2021 Oct 3.
5
Spotlight influenza: Estimation of influenza vaccine effectiveness in elderly people with assessment of residual confounding by negative control outcomes, Finland, 2012/13 to 2019/20.
Euro Surveill. 2021 Sep;26(36). doi: 10.2807/1560-7917.ES.2021.26.36.2100054.
6
Surveillance for Severe Acute Respiratory Infections among Hospitalized Subjects from 2015/2016 to 2019/2020 Seasons in Tuscany, Italy.
Int J Environ Res Public Health. 2021 Apr 7;18(8):3875. doi: 10.3390/ijerph18083875.
7
Preventing the Risk of Hospitalization for Respiratory Complications of Influenza among the Elderly: Is There a Better Influenza Vaccination Strategy? A Retrospective Population Study.
Vaccines (Basel). 2020 Jun 28;8(3):344. doi: 10.3390/vaccines8030344.
8
Assessment of enhanced influenza vaccination finds that FluAd conveys an advantage in mice and older adults.
Clin Transl Immunology. 2020 Feb 3;9(2):e1107. doi: 10.1002/cti2.1107. eCollection 2020.
9
Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine.
Influenza Other Respir Viruses. 2020 May;14(3):302-310. doi: 10.1111/irv.12714. Epub 2020 Feb 5.
10
Characteristics of hospitalizations with an influenza diagnosis, France, 2012-2013 to 2016-2017 influenza seasons.
Influenza Other Respir Viruses. 2020 May;14(3):340-348. doi: 10.1111/irv.12719. Epub 2020 Feb 5.
本文引用的文献
1
Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies.
J Infect. 2017 Nov;75(5):381-394. doi: 10.1016/j.jinf.2017.09.010. Epub 2017 Sep 18.
2
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.
Euro Surveill. 2017 Jul 27;22(30). doi: 10.2807/1560-7917.ES.2017.22.30.30580.
3
Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European Region to the WHO vaccine composition consultation for northern hemisphere 2017/18.
Vaccine. 2017 Sep 5;35(37):4828-4835. doi: 10.1016/j.vaccine.2017.07.057. Epub 2017 Aug 7.
4
Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe.
Euro Surveill. 2017 Feb 16;22(7). doi: 10.2807/1560-7917.ES.2017.22.7.30464.
5
Effectiveness of influenza vaccination programme in preventing hospital admissions, Valencia, 2014/15 early results.
Euro Surveill. 2015 Feb 26;20(8):21044. doi: 10.2807/1560-7917.es2015.20.8.21044.
6
Interim estimates of 2014/15 influenza vaccine effectiveness in preventing laboratory-confirmed influenza-related hospitalisation from the Serious Outcomes Surveillance Network of the Canadian Immunization Research Network, January 2015.
Euro Surveill. 2015 Feb 5;20(5):21024. doi: 10.2807/1560-7917.es2015.20.5.21024.
7
2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: pooled analysis from a European network of hospitals. A pilot study.
PLoS One. 2013;8(4):e59681. doi: 10.1371/journal.pone.0059681. Epub 2013 Apr 2.
Zotero 插件